×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FBLG – fibrobiologics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FBLG
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/7
08:30 am
fblg
FibroBiologics CEO Issues Letter to Shareholders
High
Report
FibroBiologics CEO Issues Letter to Shareholders
1/6
09:55 am
fblg
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
Medium
Report
FibroBiologics (NASDAQ:FBLG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $15.00 price target on the stock.
1/6
08:30 am
fblg
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
High
Report
FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
1/5
09:15 am
fblg
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease [Yahoo! Finance]
Low
Report
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease [Yahoo! Finance]
1/5
08:30 am
fblg
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
Low
Report
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
12/31
08:30 am
fblg
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
Medium
Report
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
12/16
04:05 pm
fblg
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Medium
Report
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
12/15
08:00 am
fblg
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
High
Report
FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/2
05:15 pm
fblg
Form 8-K FibroBiologics, Inc. For: Dec 30
Medium
Report
Form 8-K FibroBiologics, Inc. For: Dec 30
12/31
06:04 am
fblg
Form EFFECT FibroBiologics, Inc.
Medium
Report
Form EFFECT FibroBiologics, Inc.
12/30
04:45 pm
fblg
Form 424B3 FibroBiologics, Inc.
Medium
Report
Form 424B3 FibroBiologics, Inc.
12/29
09:35 am
fblg
Form DEFA14A FibroBiologics, Inc.
Medium
Report
Form DEFA14A FibroBiologics, Inc.
12/29
09:32 am
fblg
Form DEF 14A FibroBiologics, Inc. For: Feb 20
Medium
Report
Form DEF 14A FibroBiologics, Inc. For: Feb 20
12/18
10:17 am
fblg
Form PRE 14A FibroBiologics, Inc. For: Dec 18
Low
Report
Form PRE 14A FibroBiologics, Inc. For: Dec 18
12/18
06:37 am
fblg
Form DEF 14A FibroBiologics, Inc. For: Dec 18
Medium
Report
Form DEF 14A FibroBiologics, Inc. For: Dec 18
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: